Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: Alnylam Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Rani Therapeutics Holdings Inc. May 28, 202699.8%
-
Rani Therapeutics Holdings Inc. May 28, 202599.9%
-
Seres Therapeutics Inc. April 10, 202563.9%
-
Rani Therapeutics Holdings Inc. May 29, 202499.9%
-
Alnylam Pharmaceuticals Inc. May 16, 202492.1%
-
Rani Therapeutics Holdings Inc. May 25, 202399.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 20, 2026 | Alnylam Pharmaceuticals Inc. | Grant or award | +671 | — | — |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +9,000 | $72.01 | $648,090 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +5,153 | $128.31 | $661,181 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +4,581 | $148.77 | $681,515 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +5,228 | $151.22 | $790,578 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +4,032 | $171.95 | $693,302 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +3,454 | $189.87 | $655,811 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,985 | $430.81 | $855,158 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,938 | $432.94 | $839,038 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −2,098 | $434.50 | $911,581 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −7,675 | $435.40 | $3,341,695 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −5,358 | $436.00 | $2,336,088 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,922 | $437.56 | $840,990 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −2,086 | $438.34 | $914,377 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −5,302 | $439.27 | $2,329,010 |
Questions about Dennis A. Ausiello
What boards is Dennis A. Ausiello on?
Dennis A. Ausiello sits on the boards of Alnylam Pharmaceuticals Inc., Rani Therapeutics Holdings Inc. and Seres Therapeutics Inc.
How long has Dennis A. Ausiello served on boards?
Our records show at least 11 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.